Sotagliflozin might help patients with diabetes and chronic kidney disease who are hospitalized with heart failure avoid a readmission, study results suggest.
A low-cost, group-delivered lifestyle intervention is associated with a significantly lower risk for progression to type 2 diabetes among high-risk individuals.
Investigators evaluated whether the effects of SGLT2 inhibitors on cardiovascular, kidney and mortality outcomes are the same with and without concomitant metformin use.
An intensive lifestyle intervention was found to be associated with a significant loss of fat mass and lean mass in adults with type 2 diabetes.
About one in four U.S. adults (26.4 percent) with diabetes meet the combined goals for preventing or delaying complications of diabetes.
This study evaluated risk for type 2 diabetes among more than 1 million adolescents in Israel with and without nonalcoholic fatty liver disease.
Researchers evaluated the profile of adult-onset diabetes in patients with rheumatic diseases and identified the disease characteristics associated with insulin resistance and metabolic control.
Investigators sought to determine whether younger age at diagnosis, female sex, and higher weight z score and HbA1c are risk factors for C-peptide decline after new onset of pediatric type 1 diabetes.
The NDA for finerenone is supported by data from the double-blind, placebo-controlled phase 3 FIDELIO-DKD trial.
The study goal was to determine whether real-time continuous glucose monitoring up to 24 months is beneficial, particularly in persons living with impaired awareness of hypoglycemia.